HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $40,000 | +14.3% | 2,000 | 0.0% | 0.02% | +6.2% |
| Q3 2017 | $35,000 | +34.6% | 2,000 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $26,000 | 0.0% | 2,000 | 0.0% | 0.01% | +7.7% |
| Q1 2017 | $26,000 | +30.0% | 2,000 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $20,000 | -16.7% | 2,000 | 0.0% | 0.01% | -47.1% |
| Q3 2016 | $24,000 | +26.3% | 2,000 | 0.0% | 0.02% | +21.4% |
| Q2 2016 | $19,000 | -5.0% | 2,000 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $20,000 | -42.9% | 2,000 | 0.0% | 0.02% | -40.0% |
| Q4 2015 | $35,000 | +25.0% | 2,000 | 0.0% | 0.02% | +13.6% |
| Q3 2015 | $28,000 | -37.8% | 2,000 | 0.0% | 0.02% | -35.3% |
| Q2 2015 | $45,000 | +55.2% | 2,000 | 0.0% | 0.03% | +54.5% |
| Q1 2015 | $29,000 | +52.6% | 2,000 | 0.0% | 0.02% | +15.8% |
| Q4 2014 | $19,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
| First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
| SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
| DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
| Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
| HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
| Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
| Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |